Indication

Trypanosoma brucei gambiense infection

1 clinical trial

1 product

1 drug

Clinical trial

Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Non-parasitologically Confirmed Subjects: a Multicentre Randomised Double-blind Placebo-controlled Study

Status: Completed, Estimated PCD: 2023-08-02

Product

Drug